Articles with public access mandates - Mario CazzolaLearn more
OverallGovernment of ItalyNIHCancer Research UKFondazione CariploAIRC Foundation for Cancer Research in ItalyFWFMRCWellcomeNIHREuropean CommissionBlood Cancer UKDFGGovernment of SpainCIHRNHMRCNSERCSwedish Research CouncilOICRFWOSNSFHHMIGenome CanadaBMBFFNRSINSERMVersus Arthritis, UKBBSRCWorldwide Cancer Research, UKNMRCCPRITCanada First Research Excellence FundAHACCSPCCNSFCEMBLHelmholtzLeibniz AssociationDFFNWOKnut and Alice Wallenberg FoundationA*StarBHFInnovation Fund DenmarkV Foundation, USADamon Runyon Cancer Research FoundationNational Research Foundation, SingaporeJSTMinistry of Health, Singapore
Not available anywhere: 12
Myelodysplastic syndromes
M Cazzola
New England Journal of Medicine 383 (14), 1358-1374, 2020
Mandates: AIRC Foundation for Cancer Research in Italy
The ‘GGCC’haplotype of JAK2 confers susceptibility to JAK2 exon 12 mutation-positive polycythemia vera
D Olcaydu, RC Skoda, R Looser, S Li, M Cazzola, D Pietra, F Passamonti, ...
Leukemia 23 (10), 1924-1926, 2009
Mandates: Austrian Science Fund
Driver mutations’ effect in secondary myelofibrosis: an international multicenter study based on 781 patients
F Passamonti, B Mora, T Giorgino, P Guglielmelli, M Cazzola, M Maffioli, ...
Leukemia 31 (4), 970-973, 2017
Mandates: Fondazione Cariplo, Government of Italy
Efficacy of ruxolitinib in myeloid neoplasms with PCM1-JAK2 fusion gene
E Rumi, JD Milosevic, D Selleslag, I Casetti, E Lierman, D Pietra, ...
Annals of hematology 94, 1927-1928, 2015
Mandates: Government of Italy
LNK mutations in familial myeloproliferative neoplasms.
E Rumi, AS Harutyunyan, D Pietra, FJD Milosevic, C Cavalloni, ...
Blood 128 (1), 144-145, 2016
Mandates: Austrian Science Fund, German Research Foundation
Refractory anemia with ring sideroblasts
L Malcovati, M Cazzola
Best practice & research Clinical haematology 26 (4), 377-385, 2013
Mandates: Fondazione Cariplo
Co-mutation pattern, clonal hierarchy, and clone size concur to determine disease phenotype of SRSF2P95-mutated neoplasms
G Todisco, M Creignou, A Gallì, P Guglielmelli, E Rumi, M Roncador, ...
Leukemia 35 (8), 2371-2381, 2021
Mandates: Swedish Research Council, Government of Italy, AIRC Foundation for Cancer …
Spectrum of ASXL1 mutations in primary myelofibrosis: prognostic impact of the ASXL1 p.G646Wfs*12 mutation
G Rotunno, C Mannarelli, G Brogi, A Pacilli, F Gesullo, F Mannelli, ...
Blood, The Journal of the American Society of Hematology 133 (26), 2802-2808, 2019
Mandates: Government of Italy
Effects of mitochondrial ferritin overexpression in normal and sideroblastic erythroid progenitors
R Invernizzi, E Travaglino, MG Della Porta, A Gallì, L Malcovati, V Rosti, ...
British journal of haematology 161 (5), 726-737, 2013
Mandates: Fondazione Cariplo
Impaired virus‐specific T cell responses in patients with myeloproliferative neoplasms treated with ruxolitinib
E Rumi, E Sant'Antonio, C Cavalloni, G Comolli, VV Ferretti, I Cassaniti, ...
Hematological Oncology 38 (4), 554-559, 2020
Mandates: Government of Italy, AIRC Foundation for Cancer Research in Italy
Mutational analysis of BCORL1 in the leukemic transformation of chronic myeloproliferative neoplasms
G Rotunno, P Guglielmelli, F Biamonte, E Rumi, M Cazzola, ...
Annals of hematology 93, 523-524, 2014
Mandates: Government of Italy
Molecular and clinical presentation of UBA1-mutated myelodysplastic syndromes
M Sirenko, E Bernard, M Creignou, D Domenico, A Farina, JEA Ossa, ...
Blood, 2024
Mandates: Cancer Research UK
Available somewhere: 131
Revised international prognostic scoring system for myelodysplastic syndromes
PL Greenberg, H Tuechler, J Schanz, G Sanz, G Garcia-Manero, F Solé, ...
Blood, The Journal of the American Society of Hematology 120 (12), 2454-2465, 2012
Mandates: US National Institutes of Health, Fondazione Cariplo
The repertoire of mutational signatures in human cancer
LB Alexandrov, J Kim, NJ Haradhvala, MN Huang, AW Tian Ng, Y Wu, ...
Nature 578 (7793), 94-101, 2020
Mandates: US National Institutes of Health, Cancer Research UK, Wellcome Trust …
Clinical and biological implications of driver mutations in myelodysplastic syndromes
E Papaemmanuil, M Gerstung, L Malcovati, S Tauro, G Gundem, ...
Blood, The Journal of the American Society of Hematology 122 (22), 3616-3627, 2013
Mandates: Research Foundation (Flanders), Cancer Research UK, UK Medical Research …
Pan-cancer analysis of whole genomes
Nature 578 (7793), 82-93, 2020
Mandates: US National Institutes of Health, Cancer Research UK, UK Medical Research …
Somatic SF3B1 Mutation in Myelodysplasia with Ring Sideroblasts
E Papaemmanuil, M Cazzola, J Boultwood, L Malcovati, P Vyas, D Bowen, ...
New England Journal of Medicine 365 (15), 1384-1395, 2011
Mandates: US National Institutes of Health
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
DA Arber, A Orazi, RP Hasserjian, MJ Borowitz, KR Calvo, HM Kvasnicka, ...
Blood, The Journal of the American Society of Hematology 140 (11), 1200-1228, 2022
Mandates: US National Institutes of Health, UK Medical Research Council, National …
The evolutionary history of 2,658 cancers
M Gerstung, C Jolly, I Leshchiner, SC Dentro, S Gonzalez, D Rosebrock, ...
Nature 578 (7793), 122-128, 2020
Mandates: US National Institutes of Health, Research Foundation (Flanders), Canadian …
Mutations and prognosis in primary myelofibrosis
AM Vannucchi, TL Lasho, P Guglielmelli, F Biamonte, A Pardanani, ...
Leukemia 27 (9), 1861-1869, 2013
Mandates: Government of Italy
Publication and funding information is determined automatically by a computer program